Company Filing History:
1 out of 64 
1 out of 41 
1 out of 258 Years Active: 1990-1998
Title: Jack Gauldie: Innovator in Therapeutic Composition
Introduction
Jack Gauldie is a notable inventor based in Hamilton, Canada. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of therapeutic compositions aimed at regulating cellular invasiveness and treating various diseases. With a total of 2 patents, Gauldie's work has the potential to impact the medical community significantly.
Latest Patents
Gauldie's latest patents include innovative methods for decreasing metalloproteinase activity in patients. This involves administering a therapeutic composition comprising the cytokine oncostatin-M or its biologically active variants. Additionally, he has developed methods for increasing TIMP activity and inhibiting tumor progression through similar therapeutic compositions. His work also encompasses methods effective in treating inflammatory or degenerative diseases, stimulating erythropoiesis, and promoting healing of injuries.
Career Highlights
Throughout his career, Jack Gauldie has worked with prominent companies such as Allelix Biopharmaceuticals Inc. and Bristol Myers Squibb Company. His experience in these organizations has allowed him to refine his expertise in biopharmaceutical research and development.
Collaborations
Gauldie has collaborated with notable colleagues, including Carl Richards and Peter Michael Lansdorp. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jack Gauldie's innovative work in therapeutic compositions showcases his dedication to improving medical treatments and patient outcomes. His contributions to the field are invaluable and highlight the importance of continued research and development in biopharmaceuticals.